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Abstract
Establishment and maintenance of pregnancy in the pig involves intricate communication between the developing 
conceptuses and the maternal endometrium. This process occurs during trophoblast elongation which is 
spaciotemporally associated with conceptus synthesis and release of IL1B concomitant with pregnancy-specific 
endometrial up-regulation of IL-1 receptors, providing the potential for activation of the transcription factor, NFKB. The 
objective of the current investigation was to determine changes in expression and cellular localization of NFKB and 
associated factors during the estrous cycle and early pregnancy in the pig. In situ hybridization was used to localize 
changes in PGR, ESR1, and TNFRSF11A during the peri-implantation period. Quantitative RT-PCR was utilized to 
demonstrate gene expression changes for NFKB1, RELA, TNFRSF11A, TLR4, NFKBIA and NFKBIB. Transcription factor 
ELISA demonstrated an overall increase in RELA during the peri-implantation period in both cyclic and pregnant gilts. 
While the presence of TNFSF11A and TLR4 were both detected, TLR4 expression changes were temporally associated 
with NFKB expression and activation. Collectively, these data demonstrate that NFKB activation may occur during the 
period of uterine receptivity in both the cyclic and pregnant endometrium.
Background
Establishment of pregnancy requires changes in the
uterus that allow for attachment and implantation of a
developing conceptus. Given the fact that the uterine
transcriptional profile during early conceptus develop-
ment resembles a proinflammatory response, it is possi-
ble that the transcription factor, nuclear factor κB
(NFKB), is involved in the establishment of pregnancy.
NFKB consists of multiple subunits that have a common
Rel homology domain [1]. Inactive NFKB is sequestered
in the cytoplasm through binding to inhibitors of NFKB
(IKBs) until activation by IKB kinases, which results in
the release and ubiquitination of IKB and the subsequent
translocation of NFKB dimers into the nucleus regulating
transcription of responsive genes [1,2]. NFKB activation
can be caused by numerous stimuli such as bacterial
endotoxin lipopolysaccharide, reactive oxygen species,
and cytokines such as tumor necrosis factor α (TNF) and
interleukin-1β (IL1B). The pregnancy-specific increase of
IL1B in the uterine lumen during conceptus elongation
and attachment in pigs [3] may contribute to the activa-
tion of NFKB and the transcription of regulated genes,
such as prostaglandin synthase-2 (PTGS2). Interestingly,
PTGS2 expression is not pregnancy specific as both
expression of the gene and enzyme are up-regulated in
the luminal epithelium (LE) of gilts beginning on days 10-
12 of the estrous cycle and early pregnancy [4]. Indo-
methacin, a non-steroidal anti-inflammatory drug that
inhibits prostaglandin synthesis through NFKB activation
[5], results in the complete loss of embryos when given on
days 11 to 16 of pregnancy in the pig [6]. While elevated
PTGS2 mediated prostaglandin production by the endo-
metrium of cyclic and pregnant gilts could be mediated
by mechanisms independent of NFKB, results suggest a
relationship between the NFKB and elevated PTGS2.
We hypothesize that NFKB activation of PTGS2 tran-
scription in the uterine endometrium is in part driven [4]
by progesterone, as PTGS2 expression in the luminal epi-
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Page 2 of 17thelium is present during the estrous cycle without con-
ceptus secretion of IL1B [3] and estradiol-17β [7]. Plasma
concentrations of progesterone are high during diestrus
and cause a specific down-regulation of progesterone
receptor (PGR) protein in the luminal epithelium of pigs
on days 10 to 12 of the estrous cycle and pregnancy [8].
The down-regulation of PGR in the luminal epithelium
during the peri-implantation period is associated with
changes in endometrial gene expression that lead to
either uterine receptivity for conceptus development and
attachment or to pathways that release prostaglandin F2α
to regress the corpora lutea and initiate a return to estrus
[9]. In fact, the association between PGR down-regula-
tion and the opening of the implantation window is not
limited to the pig as PGR down-regulation in the uterine
luminal epithelium occurs prior to implantation in
humans [10,11], baboons [12], sheep [13], cattle [14] and
horses [15].
Although the specific down-regulation of PGR in the
luminal epithelium has been well established, the path-
way for this important biological event is not known. Pro-
gesterone receptor is capable of regulating the
transcription of NFKB induced genes as RELA and PGR
are mutually repressive of each other [16]. Thus, we pro-
pose that PGR expression in the uterine LE is regulated
by interactions with NFKB. The objective of this study
was to characterize the contributing factors to the activa-
tion of NFKB1 and RELA during the estrous cycle and
early pregnancy in the endometrium of the pig.
Methods
Animals
Research was conducted in accordance with the Guiding
Principles for Care and Animals use for this project was
approved by the Oklahoma State Institutional Animal
Care and Use Committee. Cyclic, crossbred gilts of simi-
lar age (8 to10 mo) and body weight (100 to 130 kg) were
observed for estrous behavior twice daily in the presence
of an intact boar. The onset of estrus was designated day
0 of the estrous cycle. Gilts were mated naturally with fer-
tile boars at the onset of their second estrus (day 0 of
estrous cycle) and again 24 h later.
Tissue collection
Once observed in estrus, gilts were randomly assigned to
be either pregnant or cyclic. Gilts destined for pregnancy
were mated by natural service from intact boars at the
onset of estrus and again 24 h later. Uteri were collected
from cyclic gilts on days 0, 5, 7.5, 10, 12, 13, 15 and 17 of
the estrous cycle whereas uteri were collected from preg-
nant gilts on days 10, 12, 13, 15 and 17. These days were
utilized as they are representative of hormonal changes
that occur during each phase of the estrous cycle and
allow for the analysis of the confounding impact concep-
tuses may contribute during pregnancy. Gilts were hys-
terectomized (n = 4 gilts/status/day) by performing a
midventral laporatomy as previously described [17]. Fol-
lowing induction of anesthesia with 1.8 mL of i.m. admin-
istration of a cocktail consisting of 2.5 mL Xylazine (100
mg/mL) and 2.5 mL Vetamine (Ketamine HCL; 100 mg/
mL) in 500 mg of Telazol (Tiletamine HCl and
Zolazepum HCl), anesthesia was maintained with a
closed circuit system of halothane (5%) and oxygen (1.5
liters/min). Immediately following removal, each uterine
horn from both cyclic and pregnant gilts was flushed with
20 mL of a physiological saline and conceptuses were
removed. Following flushing, one uterine horn was cut
along its anti-mesometrial border and endometrial sam-
ples representing several regions of the uterine horn (5
to10 g) was removed with sterile scissors and snap-frozen
in liquid nitrogen and stored at -80°C until analysis. Cross
sections of uteri were also fixed in 4% paraformaldehyde
and dehydrated in 70% ethanol to use for in situ hybrid-
ization.
RNA isolation
Total RNA was extracted from uterine endometrium by
using the RNAwiz reagent (Ambion, Inc., Austin, TX)
according to manufacturer's recommendations. Approxi-
mately 500 mg of endometrium was homogenized in 5
mL RNAwiz reagent using a Virtishear homogenizer (Vir-
tis Company Inc., Gardiner, NY). The RNA pellets were
rehydrated in nuclease-free H2O and stored at -80°C. The
RNA content was estimated spectrophotometrically and
purity estimated using the 260:280 ratio. RNA quality and
integrity was assessed by using gel electrophoresis and no
differences between samples were noticed.
Protein extraction
Cytoplasmic and nuclear protein fractions were prepared
using a previously established method [18,19]. Briefly, 5.0
mg of endometrium from cyclic (days 5, 10 and 13) and
pregnant (days 10 and 13) gilts (n = 4/day/status) was pul-
verized in liquid nitrogen. Pulverized tissue was re-sus-
pended in lysis buffer [150 mM NaCl, 10 mM Hepes-
KOH (pH 7.9), 1 mM ethylenediaminetetraacetic acid
(EDTA), 0.6% NP-40 and 1× Protease inhibitor cocktail
(Pierce Biotechnology, Rockford, IL)] and homogenized
with a loosely fitted pestle in a Dounce homogenizer
(Wheaton, Millville, NJ). The homogenate was centri-
fuged at 1000 × g for 1 min at 4°C, and then the superna-
tant was transferred to a new tube, incubated in ice for 5
min followed by additional centrifugation at 3300 × g, for
5 min at 4°C. The supernatant, containing the cytoplas-
mic protein fraction was transferred and stored at -80°C
while the pelleted nuclei were resuspended in 200 μl of
nuclear extraction buffer [25% glycerol, 20 mM Hepes
KOH (pH 7.9), 420 mM NaCl, 1.2 mM MgCl2, 0.2 mM
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inhibitor cocktail]. Resuspended nuclei were incubated
on ice for 30 min and vortexed intermittently. The
nuclear suspension was centrifuged at 12 000 × g for 5
min at 4°C. Following centrifugation, the supernatant
containing the nuclear protein extract was transferred to
a new tube and stored at -80°C. Total protein concentra-
tions were determined using the method of Bradford [20]
through the Bio-Rad protein assay (Bio-Rad Laboratories,
Hercules, CA).
RELA ELISA
The presence of the NFKB subunit RELA in nuclear and
cytoplasmic protein extractions was determined using
the TransAM NFKB RELA transcription factor assay kit
(Active Motif, Carlsbad, CA). The assay uses a 96-well
format for which each well contains immobilized oligo-
nucleotide containing the NFKB consensus sequence.
NFKB RELA was assayed in both nuclear and cytoplas-
mic protein fractions collected from endometrium of
gilts on days 5, 10 and 13 of the estrous cycle and days 10
and 13 of pregnancy (n = 4 gilts per status/day). All sam-
ples, positive control nuclear extract, and blank (using
nuclear extraction buffer) were assayed in duplicate
according to the manufacturer's recommendations. Posi-
tive control nuclear extract was included in the kit and
excess wild-type and mutated NFKB consensus sequence
oligo was added in excess to other control wells to deter-
mine specificity. Following protein/DNA binding and
washing of the wells, anti-RELA primary and HRP-conju-
gated secondary antibodies, included with the assay kit,
were used to determine relative amounts of bound RELA.
Following secondary antibody binding, the wells were
developed colorimetrically and absorbance at 450 nm
was determined. The optical density (OD) for each sam-
ple was first corrected by subtraction of the OD of the
blank and subsequently corrected for total protein in the
sample.
Histological localization of RELA
Immunohistochemistry was conducted using a rabbit
anti-human polyclonal antibody for the RELA subunit of
NFKB (sc-372; Santa Cruz Biotechnology, Santa Cruz,
CA) as primary antibody at a working concentration of 2
μg/mL. Donkey anti-rabbit secondary antibody contain-
ing a fluorescent Cy2 conjugate (711-225-152, Jackson
ImmunoResearch Laboratories, West Grove, PA) was
used for fluorescent detection. Negative control slides
were also developed where a substituting non-immune
serum for the primary antibody. Tissue sections were
then scored for nuclear localization of NFKB in uterine
luminal epithelial (LE) cells by three individuals who were
blinded to pregnancy status and day. The scoring was
based upon nuclear fluorescent intensity and done inde-
pendently by the three individuals using a 0 to 5 scale
where 0 indicated no nuclear localization and 5 indicated
high nuclear localization.
In situ hybridization
The location of progesterone receptor (PGR), estrogen
receptor 1 (ESR1, also known as estrogen receptor α), and
receptor activator of NFKB (TNFRSF11A, also known as
Receptor Activator of NFKB (RANK)) mRNA was deter-
mined in porcine uterine cross-sections by radioactive in
situ hybridization using methods previously described
[21]. Paraffin-embedded cross-sections (~5 μm) were
deparaffinized, rehydrated, and deproteinated; then
hybridized with radiolabeled antisense or sense porcine
cRNA probes (5.0 × 106 counts per minute/slide) synthe-
sized through in vitro transcription with [α-35S] uridine
5-triphosphate (MP Biomedicals, Irvine, CA) using a lin-
earized plasmid template. Following the hybridization
washes, and RNase A digestion, hybridized slides were
exposed to Biomax maximum resolution film (Eastman
Kodak, New Haven, CT) overnight to determine signal
strength. Autoradiography was performed using NTB liq-
uid photographic emulsion (Eastman Kodak). Slides were
dipped in emulsion and exposed at 4°C based on the
strength of signal from the Biomax film (2 weeks for PGR
and ESR1, and 8 weeks for TNFRSF11A), developed in
Kodak D-19 developer, counterstained with Harris modi-
fied hematoxylin (Fisher Scientific, Fairlawn, NJ), dehy-
drated, and protected with cover slips.
Digital photomicrographs of in situ hybridization,
brightfield and darkfield images of liquid emulsion auto-
radiography, were collected using a Nikon Eclipse E6000
microscope interfaced with the CoolSNAPcf digital cam-
era equipped with a cooled charge-coupled device (Pho-
tometrics, Tucson, AZ) and imaging software (MetaVue,
Molecular Devices, Downington, PA).
Quantitative one-step RT-PCR
Quantitative analysis of RELA, NFKB1, TNFRSF11A,
Toll-like receptor-4 (TLR4), and inhibitors of κB (NFK-
BIA and NFKBIB) and were assayed using quantitative
real-time RT-PCR and a fluorescent reporter as previ-
ously described [4]. PCR amplification was conducted
using the ABI PRISM 7500 Sequence Detection System
(PE Applied Biosystems, Foster City, CA). Real-time
detection during each amplification cycle was done by
using a sequence specific dual-labeled fluorescent probe
designed to have a 5' reporter dye (6-FAM) and a 3'
quenching dye (TAMRA) nested between the forward
and reverse sequence specific primers. All primers and
probes utilized for quantitative analysis for each target
gene are presented in Table 1. PCR reactions were con-
ducted using the qRT-PCR kit (Eurogentec North Amer-
ica, San Diego, CA). One hundred nanograms of RNA
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cycling conditions using the dual labeled probe were 50°C
for 30 min, 95°C for 15 min, followed by 40 repetitive
cycles of 95°C for 15 sec and a combined annealing/
extension stage, 59°C for 1 min. Fluorescent data acquisi-
tion was done during the annealing/extension phase.
Based on previous experiments for our lab, 18S ribosomal
RNA was assayed as a normalization control to correct
for loading discrepancies [3] using a commercially avail-
able primer set (Eurogentec North America, San Diego,
CA). Following RT-PCR, quantitation of gene amplifica-
tion was made by determining the cycle threshold (CT)
based on the fluorescence detected within the geometric
region of the semilog view of the amplification plot. Rela-
tive quantitative analysis of target gene expression was
evaluated using the comparative CT method as previously
described [4,22]. The ΔCT value was determined by sub-
tracting the target CT of each sample from its respective
ribosomal 18S CT value. Calculation of ΔΔCT involves
using the single greatest sample ΔCT value (the sample
with the lowest expression) as an arbitrary constant to
subtract from all other sample ΔCT values. Relative
mRNA units for each sample were calculated assuming
an amplification efficiency of 2 during the geometric
region of amplification, and applying the equation, 2ΔΔCt.
Relative mRNA units are presented as mean ± SEM.
Statistical analysis
Statistical analysis was conducted to determine differ-
ences for the RELA assay of endometrial extract, histo-
logical determination for RELA nuclear translocation,
and the quantitative RT-PCR results. For RELA assay
Table 1: Primer and probe sequences used for quantitative RT-PCR analysis
Targeta Forward/Reverse 
Primers (5' T 3')b
Fluorescent Reporterc Length of Amplicond GenBank Accession #e
TNFRSF11A GCTGACTCTGGAAGA
GAAGGTGTT
ATGTGCTGTCCAGACG
GTGGTGGTGCCTGT
192 bp CB475057
GCCCTGTCCACATATT
CGTCTTCTGT
TLR4 ATGGCCTTTCTCTCCTG
CCTGA
ATCTGAGAGCTGGGA
CCCTTGCGTGCAGGT
139 bp AB188301
AGGTCCAGTATCTTGA
CTGATGTGGG
NFKB1 CCCATGTAGACAGCAC
CACCTATGAT
ACCAGGCTGGCAGCTC
TCCTCAAAGCAGCA
132 bp NM_001048232
ACAGAGGCTCAAAGTT
CTCCACCA
RELA ACATGGACTTCTCAGC
CCTTCTGA
ACACCTGCTCTGCCCA
GAGCACTGGGTT
168 bp CN155798
CCGAAGACATCACCCA
AAGATGCT
NFKBIA TGTGATCCTGAGCTCC
GAGACTTT
TCTACACCTTGCCTGT
GAGCAGGGCTGCCT
143 bp NM_001005150
TTGTAGTTGGTGGCCT
GCAGAATG
NFKBIB TCATTCTGCAGGTCCA
GGTACTCA
TGGATTTCCTCCTGGG
CTTTGCTGCTGGCA
89 bp AK231853
CACTTGGCGGTGATTC
ATCAGCAT
aThe amplification target: TNFRSF11A, Receptor activator of NFKB; TLR4, Toll-like receptor 4; NFKB1; RELA, NFKBIA and NFKBIB, Inhibitors of κB 
α and β, respectively.
bThe forward and reverse DNA oligos used in the amplification of the target. Forward and reverse do not necessarily indicate the in vivo 
direction of transcription.
cThe DNA oligo sequence of the dual-labeled probe (possessing the FAM reporting dye on the 5' end and the TAMRA quenching dye on the 
3' end) used to measure amount of amplified target during each cycle of quantitative RT-PCR.
dThe length of the amplicon created during PCR.
eThe accession number to the porcine sequence that was utilized during primer and probe design.
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using the corrected OD values through PROC MIXED of
the Statistical Analysis System and was conducted to
determine the probably that day, pregnancy status, and
protein fraction; as well as all possible interactions
affected the observations. Data are presented as mean ±
SEM. For nuclear translocation, the average nuclear
localization score for the three evaluators was calculated
and subjected analyzed by using PROC MIXED (SAS).
The statistical model included the effects of day, preg-
nancy status, and the day by pregnancy status interaction.
Quantitative RT-PCR ΔCT values; representing the raw,
normalized data, were used for analyses, also through
PROC MIXED. Analysis of endometrial gene expression
tested for the effect of day and status; and day × preg-
nancy status interactions to determine if the presence of
conceptuses influences changes that are occurring across
different days. Significance between means of specific
effects (P < 0.05) was determined by probability differ-
ences of least squares means. Figures representing rela-
tive mRNA units have superscripts above bars depicting
significant differences as determined by the ΔCT values (P
< 0.05).
Results
RELA ELISA
A day × status (P = 0.05) and status × protein fraction (P =
0.001) interaction was detected for RELA protein expres-
sion. No difference in the amount of RELA in the nuclear
fraction of the endometria was observed between the
days of the estrous cycle and pregnancy (Figure 1). How-
ever, the amount of RELA in the cytoplasmic compart-
ment was greater during the mid-luteal phase (D13)
compared to day 5. Furthermore, the amount of RELA in
the cytoplasmic fraction was greater than the amount in
the nuclear fraction on D10 and D13 in comparison to
D5, for which there was no detectable difference in RELA
between the cytoplasmic and nuclear protein fractions.
While this difference in cellular compartment was pres-
ent in both cyclic and pregnant gilts, the difference
appeared to be greater in the pregnant gilts (Figure 1).
Immunohistological localization of RELA
NFKB RELA was localized in the nucleus of uterine lumi-
nal epithelial cells during all days of the estrous cycle and
early pregnancy (Figure 2). In addition, RELA was also
localized in the underlying stromal cells and the glandu-
lar epithelium in most samples and was highly detectable
on days 13 and 15 of pregnancy. Translocation of the
transcription factor into the nucleus of luminal epithelial
cells was affected by pregnancy status (P = 0.004), but not
by day (P = 0.11) or a day × status interaction (P = 0.13)
(Figure 3). The greatest amount of RELA translocated to
the nucleus was on D12 and D13 of pregnancy, during the
opening of the implantation window.
In situ hybridization
Estrogen receptor 1
Endometrial ESR1 mRNA was most abundant in the uter-
ine luminal epithelia (LE), glandular epithelia (GE) and
stroma (ST) at estrus (day 0) (Figure 4). By D5, expression
was still apparent in all cell types of the endometrium
albeit at a reduced abundance. Decline in ESR1 abun-
dance continued in all cell types being nearly devoid by
D7.5 of the estrous cycle and D10 of both the estrous
cycle and pregnancy. On D12 of pregnancy, ESR1 mRNA
abundance was elevated in the LE. Expression during D12
of the estrous cycle was modest compared to D13 cyclic
endometrium exhibiting elevated ESR1 mRNA in the GE.
In the GE, ESR1 mRNA was transient as expression in
cyclic gilts steadily increased in the LE on D15 and D17 of
the estrous cycle. While ESR1 expression on D15 of was
similar between cyclic and pregnant gilts, by day 17 LE
expression was much less during pregnancy (Figure 4).
Progesterone receptor
Similar to ESR1 mRNA, PGR mRNA was present in the
LE, GE and ST at estrus (D0) and was substantially lower
thereafter (Figure 5). PGR mRNA on D7.5 and D10 of the
estrous cycle was detectable, although greatly reduced,
while it was near devoid in the uterine epithelium by D12
of the estrous cycle and early pregnancy except for
expression persisting in the ST cells. PGR expression
remained at the lowest level throughout the remainder of
the estrous cycle and pregnancy until its expression
began to increase in the LE of cyclic gilts following luteol-
ysis while remaining very low to undetectable in the LE at
D15 and D17 in pregnant gilts (Figure 5).
Receptor activator of NFKB
TNFRSF11A expression in the uterus was undetectable
for many of the days of the estrous cycle and pregnancy
although the greatest expression appeared to occur in LE
on D0 during estrus. The expression was visible, although
modestly, in the LE and ST during the mid-luteal phase,
D10 to D13 of both cyclic and pregnant gilts (Figure 6).
While LE expression of TNFRSF11A was low on D15 and
D17 of the estrous cycle, LE expression in pregnant gilts
was devoid on the same days (Figure 6).
Quantitative RT-PCR
We conducted quantitative RT-PCR to determine expres-
sion changes of TNFRSF11A and TLR4 (receptors capa-
ble of inducing NFKB activity) and two genes that encode
subunits for NFKB (RELA and NFKB1).
NFKB mediating receptors
There was no significant day (P = 0.92) or status (P =
0.34) effect detected for the expression of TNFRSF11A.
Messenger RNA levels were not different in uterine endo-
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early pregnancy in pigs (Figure 7).
There was a day × status interaction (P = 0.017) on the
mRNA abundance for TLR4 (Figure 7). Expression was
lowest on D5 of the estrous cycle and greatest on D13 of
pregnancy. While expression on D10 through D17 of the
estrous cycle were greater than D5 and D7.5 (P < 0.05),
endometrium of pregnant gilts expressed significantly
more TLR4 mRNA transcript than cyclic gilts on D10,
D12, D13, D15 and D17 (P < 0.05).
NFKB subunits: NFKB1 and RELA
A significant day × pregnancy status interaction was
detected for NFKB1 gene expression (P < 0.01). Messen-
ger RNA abundance for NFKB1 was greatest during
estrus and least on day 5 (Figure 8). NFKB1 expression
increased steadily during diestrus being 2 to 3-fold
greater in endometrium collected from D12, D13, D15
and D17 compared to D5 (P < 0.05). On D13 of gestation,
expression was about 2-fold greater when compared to
D13 of the estrous cycle (P < 0.05) while the inverse was
true when comparing D17 of the estrous cycle and preg-
nancy (Figure 8).
Similar to NFKB1, a day × status interaction (P < 0.013)
affected the mRNA abundance of RELA in the endome-
trium from cycle and pregnant gilts. Like the NFKB1 sub-
unit, RELA expression was greatest in endometrium
collected during estrus, about 4-fold greater than D5 of
the estrous cycle which was the lowest expression of
RELA mRNA. After D5 of the estrous cycle, expression
increased in both cyclic and pregnant gilts on D10, D12,
D13, and D15 (P < 0.05; Figure 8). While expression
remained elevated on D17 of the estrous cycle, expression
returned to basal levels on D17 of gestation, representing
about a 2.3-fold difference in gene expression (P < 0.05).
Inhibitors of NFKB
Gene expression for NFKBIA was affected by day (P =
0.001) but not status (P = 0.15). Status did not affect the
expression of NFKBIA (P = 0.23). NFKBIA mRNA abun-
dance was greatest during estrus, being at least 7-fold
greater in comparison to all other days assayed (P < 0.05).
There were no differences in gene expression between all
other days as mRNA abundance remained at a consistent
level from days 5 through 17 (Figure 9).
There was a tendency for a day × status interaction (P =
0.08), day (P = 0.07) and status (P = 0.09) for NFKBIB
gene expression. The greatest expression differences
existed during estrus and day 17 of estrous cycle. NFKBIB
mRNA abundance was greater (P < 0.05) in endometrium
Figure 1 Transcription factor assay to determine relative amounts of activated RELA. Nuclear (light bars; day effect, P = 0.005) and cytoplasmic 
(dark bars; day effect, P = 0.006; status effect, P < 0.001) protein fractions of endometrium collected from gilts on days 5, 10 and 13 of the estrous cycle 
and days 10 and 13 of pregnancy (n = 4/day/status). Relative optical density for each sample was corrected for total protein concentration in the sam-
ple. Data is presented as relative O.D. mean ± SEM.
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0 but was about 2-fold greater compared to all other days
during diestrus and early pregnancy (days 5 to 15). No
differences were detected between days 5 to 15 of the
estrous cycle or pregnancy (Figure 9).
Discussion
The establishment of pregnancy requires diversion from
the pathway of cyclicity and return to estrus following the
opening of the implantation window and uterine recep-
tivity in pigs. Progesterone-driven transcriptional regula-
tion of specific endometrial factors during the mid-luteal
phase contributes to both induction of luteolysis resulting
in return to estrus in cyclic animals and conceptus
growth and expansion to establish pregnancy in mated
females. We have suggested a relationship between PGR
expression and the activation of NFKB in the endometrial
LE regulates the transcription of specific genes such as
PTGS2 [4,9].
Establishment of pregnancy in mice has been shown to
involve the NFKB system. Not only does the activation of
NFKB during the implantation window in mice occur
[19]; it has also been shown to be required for uterine
receptivity through its affects on leukaemia inhibitory
factor (LIF) expression, as LIF administration restores
normal implantation during pregnancy when NFKB
function is compromised [23]. Interestingly, peak LIF
secretion by the pig uterus occurs on day 12 of the
Figure 2 Immunolocalization of RELA in uterine endometrium. Endometrium from days 10, 12, 13, 15 and 17 of the estrous cycle (C) and days 10, 
12, 13, 15, and 17 of pregnancy (P) were immunostained for RELA. Images are representative from four biological replications. A representative section 
from d 15 of pregnancy immunolocalized without either the primary or secondary antibody served as negative controls.
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Figure 3 Translocation of RELA in the luminal epithelial cells. Nuclear translocation was visually determined and assigned a score; 0 being no lo-
calization within the nucleus and 5 being significant localization within the nucleus. Translocation of an activated NFKB heterodimer, as determined 
through RELA antibody binding, was affected by pregnancy status (P = 0.004) but not by day (P = 0.11) or day × status interaction (P = 0.13). Dark bars 
represent days of pregnancy and light bars represent days of the estrous cycle. Data are presented as mean score ± SEM.
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Figure 4 In Situ hybridization analysis of ESR1 mRNA expression in porcine endometrium. Protected transcripts in endometrium from days 0, 
5, 7.5, 10, 12, 13, 15 and 17 of the estrous cycle and days 10, 12, 13, 15 and 17 of pregnancy were visualized by liquid emulsion autoradiography and 
imaged under bright-field and dark-field illumination. Note the greatest expression is prior to (day 17), during (day 0) and after estrus (day 5). ESR1 
expression is abundant in the luminal epithelium (LE) and glandular epithelium (GE) during days 0 and 5 while only in the LE on day 17 of the estrous 
cycle. A representative day 5 section was hybridized with radiolabeled sense cRNA probe to serve as a negative control. All other images are repre-
sentative from four biological replications. 4× Objective and 10× eyepiece for original magnification 40×.
Ross et al. Reproductive Biology and Endocrinology 2010, 8:39
http://www.rbej.com/content/8/1/39
Page 10 of 17
Figure 5 In Situ hybridization analysis of PGR mRNA expression in porcine endometrium. Protected transcripts in endometrium from days 0, 5, 
7.5, 10, 12, 13, 15 and 17 of the estrous cycle and days 10, 12, 13, 15 and 17 of pregnancy were visualized by liquid emulsion autoradiography and 
imaged under bright-field and dark-field illumination. Note the greatest expression is during (day 0) and after estrus (day 5) abundant in the luminal 
epithelium (LE) and glandular epithelium (GE) and stromal (ST) cell types. PGR expression is greatly reduced in the LE and GE by day 10 and nearly 
devoid on day 12 of the estrous cycle and pregnancy, although still present in ST cells. A representative day 5 section was hybridized with radiolabeled 
sense cRNA probe (sense) to serve as a negative control. All other images are representative from four biological replications. 4× Objective and 10× 
eyepiece for original magnification 40×.
Figure 6 In Situ hybridization analysis of receptor activator of NFKB (TNFRSF11A). Protected transcripts in endometrium from days 0, 5, 7.5, 10, 
12, 13, 15 and 17 of the estrous cycle and days 10, 12, 13, 15 and 17 of pregnancy were visualized by liquid emulsion autoradiography and imaged 
under bright-field and dark-field illumination. While expression was low in all tissues evaluated, evidence of TNFRSF11A expression is detected in the 
LE on day 12 of the estrous cycle and pregnancy. A representative day 12 pregnant section was hybridized with radiolabeled sense cRNA probe (sense) 
to serve as a negative control. All other images are representative from four biological replications. 4× objective and 10× eyepiece for original mag-
nification 40×.
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Figure 7 Relative mRNA abundance for receptor mediators of NFKB activation. Expression differences for endometrial TNFRSF11A (Top panel; 
effect of day, P < 0.93; effect of status, P = 0.34) and TLR4 (Lower panel; day × status effect, P = 0.017), in cyclic (light bars) and pregnant (dark bars) gilts. 
Relative abundance of mRNA was calculated from the quantitative RT-PCR analysis as described in Materials and Methods. Bars without common low-
ercase superscripts represent a statistical difference (P < 0.05) between day/status combinations. Superscripts are not included in the upper panel as 
no main or interacting effects were detected. Relative mRNA units are presented as mean ± SEM.
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Figure 8 Relative mRNA abundance for NFKB subunits. Expression differences for endometrial NFKB1 (Top panel; day × status interaction, P < 0.01) 
and RELA (Lower panel; day × status effect, P = 0.017), in cyclic (light bars) and pregnant (dark bars) gilts. Relative abundance of mRNA was calculated 
from the quantitative RT-PCR analysis as described in Materials and Methods. Bars without common lowercase superscripts represent a statistical dif-
ference (P < 0.05) between day/status combinations. Relative mRNA units are presented as mean ± SEM.
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Figure 9 Relative mRNA abundance for endometrial inhibitors of NFKB activation. NFKBIA (Top panel; effect of day, P < 0.001) and NFKBIB (Lower 
panel; day × status effect, P = 0.079), in cyclic (light bars) and pregnant (dark bars) gilts. Relative abundance of mRNA was calculated from the quanti-
tative RT-PCR analysis as described in Materials and Methods. Bars without common lowercase superscripts represent a statistical difference (P < 0.05) 
between day/status combinations whereas differences in uppercase superscripts represent statistical differences between days of gestation. Relative 
mRNA units are presented as mean ± SEM.
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Page 15 of 17estrous cycle [24], as well as up-regulation of uterine
PTGS2 [4], an NFKB regulated gene [5,25], and we now
demonstrate an increased NFKB1 and RELA gene expres-
sion, both of which can be induced through NFKB [26].
These NFKB regulated factors are all in congruence with
the opening of the implantation window in the pig. Based
on the expression patterns of these genes in conjunction
with the RELA ELISA it appears that transcriptional con-
trol of uterine endometrium during the initiation of
implantation is regulated by NFKB possessing the RELA
subunit, and that during pregnancy, NFKB is more
actively translocated into the nucleus in the luminal epi-
thelium.
Steroid hormones, as well as their receptors, have in
many studies been shown to affect NFKB activity in a
variety of tissues. Kalkhoven et al. [16] demonstrated the
ability of both PGR and NFKB RELA to be mutually
repressive of each other, which suggests that the loss of
PGR during the opening of the implantation window may
be related to elevated expression of NFKB regulated
genes in the uterine endometrium during the estrous
cycle and early pregnancy. Loss of PGR expression in the
uterine LE is temporally associated with uterine receptiv-
ity in the pig and other numerous mammalian species
[10-15]. The ability for PGR down-regulation to affect the
timing of uterine receptivity appears to carry over into
the timing of the overall length of estrous cycle.
The hypothesis that progesterone induced loss of PGR
regulates uterine receptivity and the estrous cycle is sup-
ported by the demonstration of shortened estrous cycles
in sheep and cattle given progesterone supplementation
shortly after estrus, prior to normal endogenous proges-
terone secretion by the corpora lutea [27,28]. Addition-
ally, administration of the PGR antagonist, mifepristone,
on days 3-5 of the ovine estrous cycle results in a delay of
luteolysis [29]. Collectively, these studies suggest that
PGR is involved in the regulation of prostaglandin (PG)
production. Indomethacin, an inhibitor of NFKB induced
PTGS2 expression [5], when given to pigs during early
gestation ablates PG production [6], suggesting that uter-
ine PG production during diestrus in the pig is NFKB
regulated. Demonstrating that altering either PGR
expression levels or NFKB activation, these studies inde-
pendently suggest the ability of both PGR and NFKB to
regulate PG production during the period of luteolysis.
The temporal affiliation between the gene expression
patterns of TLR4 and TNFRSF11A and NFKB inducible
genes; NFKB1, RELA, PTGS2 [4] and LIF [24] in the uter-
ine LE is suggestive of the involvement of TLR4 and/or
TNFRSF11A during the activation of NFKB during the
initiation of uterine receptivity during the estrous cycle
and early pregnancy in pigs. Because a mutual repression
between RELA and PGR exists [16], what regulates this
activation of NFKB and potentially, the subsequent
down-regulation of PGR in the uterine endometrium
remains unclear. The expression of TNFRSF11A and its
ligand (TNSF11), both involved in bone remodeling and
mammary gland development [30,31], provide one such
potential mechanism. Expression of TNSF11 can be stim-
ulated by progesterone [32] suggesting the potential of
TNFRSF11A mediated NFKB activation in the pig endo-
metrium if TNSF11 is capable of signaling through endo-
metrial stromal cells which still express PGR during the
implantation window in the pig [8]. This novel hypothesis
has been presented [9] and is supported by the expression
of TNFRSF11A in the uterine endometrium; however no
communications to our knowledge have indicated the
presence of TNFRSF11A or its ligand in the uterus of
other mammalian species.
TLR4 also provides a likely mechanism of NFKB activa-
tion in the pig as its expression pattern is temporally
associated with that of the NFKB regulated genes, PTGS2
[4], LIF [24], and the NFKB1 and RELA in the pig uterine
endometrium. TLR4 expression has been demonstrated
in endometrial LE of a variety of species. In addition to
the pig, TLR4 has also been shown to be expressed in the
uterine LE and ST of mice [33], women [34,35] and cattle
[36]. While TLR4 was originally described for its ability
to respond to the gram-negative cell wall component,
lipopolysaccharide (LPS; Poltorak et al., 1998) recent data
suggests a variety of endogenous ligands, such as heat
shock proteins (HSPs) 60 and 70, fibrinogen, fibronectin,
heparan sulfate, certain β-defensins, and high mobility
group box 1 protein also possess the ability to stimulate
TLR4 signaling [37]. While the suggestion that TLR4
expression in the uterus allows the ability to respond to
foreign bacterial pathogens is valid, its roles in uterine
biology in conjunction with endogenous ligand expres-
sion should not be overlooked. Of the other mentioned
endogenous ligands, fibronectin and heparan sulfate have
both been suggested to be involved in the attachment of
the pig conceptus to the uterine LE [38], occurring tem-
poral and spatially to TLR4 increased expression in the
uterine endometrium.
Based on these data and the literature presented hith-
erto, we hypothesize that NFKB activation is a critical
component to the opening of the implantation window in
pigs. However, stringent regulation of NFKB activation is
necessary to prevent a severe inflammatory response,
which could otherwise potentially compromise preg-
nancy. It is possible that the conceptus could augment the
activation of NFKB through at least two mechanisms.
The first possible mechanism is the spatiotemporal peak
in conceptus secretion of IL1B with uterine expression of
IL1 receptors on day 12 of gestation [3]. The second pos-
sible mechanism for augmented NFKB activation is
through conceptus expression of TLR4 endogenous
ligands; fibronectin and fibrinogen [37], both of which
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Page 16 of 17are up-regulated 8.9 and 12.8 fold during days 11 to 14 of
gestation, respectively [39]. Both of these mechanisms
seem plausible as the amount of cytoplasmic RELA
sequestered in the cytoplasm was greatest on day 13 of
pregnant gilts compared to cyclic gilts. Bovine endome-
trial explants respond to LPS, the bacterial TLR4 ligand,
by increasing PG production, with a notable increased
PGE to PGF ratio, while in vitro stimulation of LE or ST
cells with LPS resulting in PTGS2 gene expression could
be ablated with an LPS antagonist [36]. Prostaglandin
production peaks during the mid-luteal phase for both
PGE and PGF during both the estrous cycle and preg-
nancy in the pig; however, a marked increase in the
PGE:PGF ratio is detected in pregnant gilts compared to
cyclic gilts [40], further suggesting a relationship between
pregnancy PG production ratios and TLR4 conceptus
stimulation.
While both the RELA ELISA and RELA immunohis-
tochemistry suggest the presence of RELA in the endo-
metrium it is difficult to accurately identify in in vivo
samples the precise timing of nuclear translocation as it
generally occurs very rapidly and can be tightly regulated.
Total endometrial RELA detected was greatest in preg-
nant gilts supports conceptus augmented NFKB activa-
tion, however the majority appears limited to the
cytoplasm, indicative of regulatory mechanisms prevent-
ing overwhelming inflammatory response. The concomi-
tant estrogen secretion by the conceptus [7] temporal to
conceptus production of both IL1B and endogenous
TLR4 ligands may be one way NFKB transcriptional
activity is regulated. Estrogen, signaling through ESR1
and not ESR2, has the in vitro ability to prevent activated
NFKB in the cytoplasm from being translocated into the
nucleus of the cell and inducing transcription [41]. Inter-
estingly, the up-regulation of ESR1 on days 12 and 13 of
gestation in the uterine LE is temporally associated with
the elevated uterine luminal estradiol-17β [7] and the
pregnancy associated elevation of activated RELA in the
cytoplasmic protein fractions. Typically, the degradation
of NFKB inhibitors results not only in the ability for the
activated NFKB dimer to bind DNA, but also exposes the
nuclear localization signal necessary for expedited trans-
port to the nucleus of the cell [2]. These data suggest that
while the NFKB1/RELA is capable of binding DNA, the
heterodimer remains primarily in the cytoplasm of the
cell. The temporal relationship of endometrial ESR1
expression and conceptus estradiol secretion [7,42] may
provide a potential mechanism by which this occurs. If
this mechanism does occur during pregnancy in the pig,
it is likely that other mechanisms are also in place as cyto-
plasmic RELA also increases in uterine endometrium
from gilts during the estrous cycle.
The opening of the implantation window is the initiat-
ing point of the period during gestation at which specific
endometrial alterations occur to allow the attachment of
the conceptus trophectoderm. It is this period of develop-
ment that requires the formation of a communication
network between the developing conceptus and the
maternal endometrium with dysfunction on the part of
resulting in the inability to establish pregnancy. Steroid
hormones, progesterone and estrogen, no doubt serve a
fundamental responsibility in the pattern of endometrial
secretions and the induction of uterine receptivity. The
steroid hormone receptors ESR1 and PGR, through their
ability to affect the transcriptional activity of NFKB, are
likely a critical component to inducing and regulating the
degree of transcription necessary in the uterine endome-
trium for the establishment of pregnancy in the pig.
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